Literature DB >> 30867235

EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae.

M M Sfeir1, J A Hayden2, K A Fauntleroy3, C Mazur2, J K Johnson4, P J Simner5, S Das6, M J Satlin1, S G Jenkins1,2, L F Westblade7,2.   

Abstract

The increase in the prevalence and impact of infections caused by carbapenemase-producing Enterobacteriaceae is a global health concern. Therefore, rapid and accurate methods to detect these organisms in any clinical microbiology laboratory, including those in resource-limited settings, are essential to prevent and contain their spread. It is also important to differentiate between serine- and metal-dependent carbapenemases elaborated by carbapenemase-producing isolates for epidemiologic, infection control and prevention, and therapeutic purposes. Here, we describe the development and evaluation of the EDTA-modified carbapenem inactivation method (eCIM), an assay for discriminating between serine- and metal-dependent (i.e., metallo-β-lactamases [MBLs]) carbapenemases when used in conjunction with the modified carbapenem inactivation method (mCIM). The eCIM had an overall sensitivity and specificity of 100% and was adopted by the Clinical and Laboratory Standards Institute as a method to use in combination with the mCIM to identify MBL-producing Enterobacteriaceae.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  EDTA-modified carbapenem inactivation method; MBL; carbapenemase; carbapenemase-producing Enterobacteriaceaezzm321990; eCIM; mCIM; metallo-β-lactamase; modified carbapenem inactivation method; phenotypic detection

Year:  2019        PMID: 30867235      PMCID: PMC6498035          DOI: 10.1128/JCM.01757-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 2.  Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.

Authors:  Stephanie M Pouch; Michael J Satlin
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

3.  Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.

Authors:  Pranita D Tamma; Katherine E Goodman; Anthony D Harris; Tsigereda Tekle; Ava Roberts; Abimbola Taiwo; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2016-11-09       Impact factor: 9.079

Review 4.  The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.

Authors:  Latania K Logan; Robert A Weinstein
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Evaluation of the modified carbapenem inactivation method and sodium mercaptoacetate-combination method for the detection of metallo-β-lactamase production by carbapenemase-producing Enterobacteriaceae.

Authors:  Kageto Yamada; Machiko Kashiwa; Katsumi Arai; Noriyuki Nagano; Ryoichi Saito
Journal:  J Microbiol Methods       Date:  2016-11-16       Impact factor: 2.363

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 7.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.

Authors:  Joseph D Lutgring; Brandi M Limbago
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods.

Authors:  Kim van der Zwaluw; Angela de Haan; Gerlinde N Pluister; Hester J Bootsma; Albert J de Neeling; Leo M Schouls
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

View more
  32 in total

1.  Current state of the art in rapid diagnostics for antimicrobial resistance.

Authors:  Rathina Kumar Shanmugakani; Balaji Srinivasan; Marshall J Glesby; Lars F Westblade; Washington B Cárdenas; Tony Raj; David Erickson; Saurabh Mehta
Journal:  Lab Chip       Date:  2020-07-09       Impact factor: 6.799

2.  Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus.

Authors:  Morgane Petit; François Caméléna; Aurélie Cointe; Thibaut Poncin; Manel Merimèche; Stéphane Bonacorsi; André Birgy; Béatrice Berçot
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

3.  Blood-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Carbapenemase-Producing Enterobacteriaceae Directly from Positive Blood Culture Broths.

Authors:  M M Sfeir; M J Satlin; K A Fauntleroy; S G Jenkins; L F Westblade
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

4.  Direct β-Lactam Inactivation Method: a New Low-Cost Assay for Rapid Detection of Carbapenemase- or Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood Culture Bottles.

Authors:  Gabriele Bianco; Matteo Boattini; Marco Iannaccone; Lucina Fossati; Rossana Cavallo; Cristina Costa
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

5.  Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa Isolates.

Authors:  Christian M Gill; Tomefa E Asempa; Isabella A Tickler; Caitlin Dela Cruz; Fred C Tenover; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

6.  Evaluation of NG-Test Carba 5 for Rapid Phenotypic Detection and Differentiation of Five Common Carbapenemase Families: Results of a Multicenter Clinical Evaluation.

Authors:  Stephen Jenkins; Nathan A Ledeboer; Lars F Westblade; C A Burnham; Matthew L Faron; Patricia J Simner; Yehudit Bergman; Rebecca Yee; Brian Mesich; Derek Gerstbrein; Meghan A Wallace; Amy Robertson; Kathy A Fauntleroy; Anna S Klavins; Rianna Malherbe; Andre Hsiung
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

7.  Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Christian M Gill; Maxwell J Lasko; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

8.  Reply to Rennie, "Zinc Concentration Affects Metallo-Beta-Lactamase Susceptibility Testing of Enterobacterales".

Authors:  Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

9.  In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan.

Authors:  Shu-Chen Kuo; Yung-Chih Wang; Mei-Chen Tan; Wei-Cheng Huang; Yih-Ru Shiau; Hui-Ying Wang; Jui-Fen Lai; I-Wen Huang; Tsai-Ling Lauderdale
Journal:  J Antimicrob Chemother       Date:  2021-07-15       Impact factor: 5.790

10.  Practical Agar-Based Disk Diffusion Tests Using Sulfamoyl Heteroarylcarboxylic Acids for Identification of Subclass B1 Metallo-β-Lactamase-Producing Enterobacterales.

Authors:  Chihiro Norizuki; Jun-Ichi Wachino; Wanchun Jin; Kouji Kimura; Kumiko Kawamura; Noriyuki Nagano; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2021-07-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.